相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery
Qiong-Qiong Yang et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy
Dinglin Zhang et al.
BIOMATERIALS (2020)
Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway
Rongrong Ni et al.
BIOMATERIALS (2020)
Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications
Yan Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Recent advances in folic acid engineered nanocarriers for treatment of breast cancer
Priti Tagde et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk
Suelene Georgina Dofara et al.
ANTICANCER RESEARCH (2020)
Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates
Hira Choudhury et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release
Wei Yin et al.
BIOMATERIALS (2019)
Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives
Salman Ahmed et al.
PHYTOMEDICINE (2019)
Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer
Kaiyuan Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Luteolin, a flavonoid, as an anticancer agent: A review
Muhammad Imran et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles
Yu Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Therapeutic applications of resveratrol nanoformulations
Divya Arora et al.
ENVIRONMENTAL CHEMISTRY LETTERS (2018)
Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies
Nur Aziz et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Advances in targeting the folate receptor in the treatment/imaging of cancers
Marcos Fernandez et al.
CHEMICAL SCIENCE (2018)
Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro
Junli Hong et al.
FRONTIERS IN PHARMACOLOGY (2018)
Specific uptake luteolin by boronate affinity-based single-hole hollow imprinted polymers sealed in dialysis bags
Xue Bai et al.
CHEMICAL ENGINEERING JOURNAL (2018)
Preparation and Characterization of Copolymer Micelles for the Solubilization and In Vitro Release of Luteolin and Luteoloside
Weixia Qing et al.
AAPS PHARMSCITECH (2017)
Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis
Yin Dou et al.
BIOMATERIALS (2017)
ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Xiaoding Xu et al.
ADVANCED MATERIALS (2017)
Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis
Anne Platel et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats
Matthew T. Cook et al.
ONCOLOGY REPORTS (2016)
Luteolin decreases the UVA-induced autophagy of human skin fibroblasts by scavenging ROS
Miaomiao Yan et al.
MOLECULAR MEDICINE REPORTS (2016)
Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
Yasunori Sato et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs
Da-Wei Sun et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
Mikhail O. Durymanov et al.
THERANOSTICS (2015)
Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts
Matthew T. Cook et al.
SPRINGERPLUS (2015)
Biocompatible Reactive Oxygen Species (ROS)-Responsive Nanoparticles as Superior Drug Delivery Vehicles
Dinglin Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity
Debatosh Majumdar et al.
CANCER PREVENTION RESEARCH (2014)
Role of membrane disturbance and oxidative stress in the mode of action underlying the toxicity of differently charged polystyrene nanoparticles
Sourav Bhattacharjee et al.
RSC ADVANCES (2014)
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Stefan Tenzer et al.
NATURE NANOTECHNOLOGY (2013)
Chemistry and biology of reactive oxygen species in signaling or stress responses
Bryan C. Dickinson et al.
NATURE CHEMICAL BIOLOGY (2011)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery
Juliana M. Chan et al.
BIOMATERIALS (2009)
Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats
Ramar Perumal Samy et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
分享论文
